{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:48:19Z","timestamp":1649126899046},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe [A]"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s00120-005-0762-3","type":"journal-article","created":{"date-parts":[[2005,2,2]],"date-time":"2005-02-02T03:38:58Z","timestamp":1107315538000},"page":"151-154","source":"Crossref","is-referenced-by-count":1,"title":["Harnblasenkarzinom"],"prefix":"10.1007","volume":"44","author":[{"given":"K.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hautmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00005392-199707000-00017","volume":"158","author":"Cookson","year":"1997","unstructured":"Cookson MS, Herr HW, Zhang ZF et al. (1997) The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158: 62?67","journal-title":"J Urol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B et al. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351: 2159?2169","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0022-5347(01)61909-8","volume":"161","author":"Hautmann","year":"1999","unstructured":"Hautmann RE, Petriconi R de, Gottfried HW et al. (1999) The ileal neobladder: complications and functional results in 363 patients after 11 years of followup. J Urol 161: 422?428","journal-title":"J Urol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1464-410X.1997.00431.x","volume":"80","author":"Herr","year":"1997","unstructured":"Herr HW (1997) Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome. Br J Urol 80: 762?765","journal-title":"Br J Urol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.bjc.6601590","volume":"90","author":"Hunter","year":"2004","unstructured":"Hunter KW (2004) Host genetics and tumour metastasis. Br J Cancer 90: 752?725","journal-title":"Br J Cancer"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-5347(17)43864-X","volume":"137","author":"Jakse","year":"1987","unstructured":"Jakse G, Loidl W, Seeber G et al. (1987) Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol 137: 39?43","journal-title":"J Urol"},{"key":"CR7","first-page":"65","volume":"29","author":"Klaen","year":"1998","unstructured":"Klaen R, Miller K (1998) Radikale Zystektomie beim T1G3-Harnblasenkarzinom?oft zu fr\u00fch? Akt Urol 29: 65?69","journal-title":"Akt Urol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","volume":"163","author":"Lamm","year":"2000","unstructured":"Lamm DL, Blumenstein BA, Crissman JD et al. (2000) Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163: 1124?1129","journal-title":"J Urol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817?2826","journal-title":"N Engl J Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0302-2838(02)00173-2","volume":"41","author":"Patard","year":"2002","unstructured":"Patard JJ, Rodriguez A, Leray E et al. (2002) Intravesical bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours. Eur Urol 41: 635?642","journal-title":"Eur Urol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0090-4295(01)01551-5","volume":"59","author":"Peyromaure","year":"2002","unstructured":"Peyromaure M, Weibing S, Sebe P et al. (2002) Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guerin therapy. Urology 59: 409?413","journal-title":"Urology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","volume":"169","author":"Shahin","year":"2003","unstructured":"Shahin O, Thalmann GN, Rentsch C et al. (2003) A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 169: 96?100","journal-title":"J Urol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000472824","volume":"13","author":"Stockle","year":"1987","unstructured":"Stockle M, Alken P, Engelmann U et al. (1987) Radical cystectomy ? often too late? Eur Urol 13: 361?367","journal-title":"Eur Urol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"Sylvester","year":"2002","unstructured":"Sylvester RJ, Meijden AP van der, Lamm DL (2002) Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168: 1964?1970","journal-title":"J Urol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.ju.0000132129.87598.3b","volume":"172","author":"Thalmann","year":"2004","unstructured":"Thalmann GN, Markwalder R, Shahin O et al. (2004) Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol 172: 70?75","journal-title":"J Urol"}],"container-title":["Der Urologe, Ausgabe A"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-005-0762-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-005-0762-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-005-0762-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:54:00Z","timestamp":1558594440000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-005-0762-3"}},"subtitle":["Konservative oder operative Therapie bei PT1G3"],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1007\/s00120-005-0762-3","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}